Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (يفتح نافذة جديدة)

CRASH-3 Trial Collaborators

Source‎: Lancet 2019;394(10210):1713-23.

مفهرسة‎: PubMed 31623894

DOI‎: 10.1016/S0140-6736(19)32233-0

https://www.ncbi.nlm.nih.gov/pubmed/31623894 (يفتح نافذة جديدة)

Alternatives to allogeneic platelet transfusion. (يفتح نافذة جديدة)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Source‎: Br J Haematol 2016;175(3):381-92.

مفهرسة‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (يفتح نافذة جديدة)

Tranexamic acid: less bleeding and less thrombosis? (يفتح نافذة جديدة)

Godier A, Roberts I, Hunt BJ.

Source‎: Crit Care 2012;16(3):135.

مفهرسة‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (يفتح نافذة جديدة)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (يفتح نافذة جديدة)

Perel P, Ker K, Morales Uribe CH, Roberts I

Source‎: Cochrane Database Syst Rev 2013;(1):CD010245.

مفهرسة‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (يفتح نافذة جديدة)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (يفتح نافذة جديدة)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Source‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

مفهرسة‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (يفتح نافذة جديدة)

Antifibrinolytic drugs for acute traumatic injury. (يفتح نافذة جديدة)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Source‎: Cochrane Database Syst Rev 2011;(1):CD004896.

مفهرسة‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (يفتح نافذة جديدة)

Use of tranexamic acid to reduce bleeding in burns surgery. (يفتح نافذة جديدة)

Tang YM, Chapman TW, Brooks P

Source‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

مفهرسة‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (يفتح نافذة جديدة)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (يفتح نافذة جديدة)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Source‎: Burns. 2022;48(3):522-28.

مفهرسة‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (يفتح نافذة جديدة)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (يفتح نافذة جديدة)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Source‎: J Blood Med 2011;2:131-4.

مفهرسة‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (يفتح نافذة جديدة)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (يفتح نافذة جديدة)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Source‎: Transfusion 2009;49 Suppl 5:240S-7S.

مفهرسة‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (يفتح نافذة جديدة)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (يفتح نافذة جديدة)

Fries D

Source‎: Transfusion 2013;53 Suppl 1:91S-5S.

مفهرسة‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (يفتح نافذة جديدة)

A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. (يفتح نافذة جديدة)

Haan J, Scalea T

Source‎: Am Surg 2005;71(5):414-5.

مفهرسة‎: PubMed 15986972

https://www.ncbi.nlm.nih.gov/pubmed/15986972 (يفتح نافذة جديدة)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (يفتح نافذة جديدة)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Source‎: J Trauma 2010;69(3):489-500.

مفهرسة‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (يفتح نافذة جديدة)

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. (يفتح نافذة جديدة)

Hsia CC, Chin-Yee IH, McAlister VC.

Source‎: Ann Surg 2008;248(1):61-8.

مفهرسة‎: PubMed 18580208

DOI‎: 10.1097/SLA.0b013e318176c4ec

https://www.ncbi.nlm.nih.gov/pubmed/18580208 (يفتح نافذة جديدة)

Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. (يفتح نافذة جديدة)

Johansson PI, Eriksen K, Alsbjørn B

Source‎: J Trauma 2006;61(4):1016-8.

مفهرسة‎: PubMed 17033583

DOI‎: 10.1097/01.ta.0000239261.48022.f1

https://www.ncbi.nlm.nih.gov/pubmed/17033583 (يفتح نافذة جديدة)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (يفتح نافذة جديدة)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Source‎: ANZ J Surg 2013;83(3):155-60.

مفهرسة‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (يفتح نافذة جديدة)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (يفتح نافذة جديدة)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Source‎: Injury 2012;43(9):1409-14.

مفهرسة‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (يفتح نافذة جديدة)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (يفتح نافذة جديدة)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Source‎: Injury 2008;39(9):1054-61.

مفهرسة‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (يفتح نافذة جديدة)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (يفتح نافذة جديدة)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Source‎: Anesthesiology 2003;98(6):1513-5.

مفهرسة‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (يفتح نافذة جديدة)

Alternatives to allogeneic platelet transfusion. (يفتح نافذة جديدة)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Source‎: Br J Haematol 2016;175(3):381-92.

مفهرسة‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (يفتح نافذة جديدة)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (يفتح نافذة جديدة)

Fries D

Source‎: Transfusion 2013;53 Suppl 1:91S-5S.

مفهرسة‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (يفتح نافذة جديدة)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (يفتح نافذة جديدة)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Source‎: Thromb Res 2014;134(2):360-8.

مفهرسة‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (يفتح نافذة جديدة)

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. (يفتح نافذة جديدة)

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B

Source‎: Br J Haematol 2013;160(2):228-36.

مفهرسة‎: PubMed 23151086

DOI‎: 10.1111/bjh.12118

https://www.ncbi.nlm.nih.gov/pubmed/23151086 (يفتح نافذة جديدة)

Strategies to reduce the use of blood products: a European perspective. (يفتح نافذة جديدة)

Theusinger OM, Felix C, Spahn DR.

Source‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

مفهرسة‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (يفتح نافذة جديدة)

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (يفتح نافذة جديدة)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Source‎: Anesthesiology 2008;109(6):1063-76.

مفهرسة‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (يفتح نافذة جديدة)

Alternatives to allogeneic platelet transfusion. (يفتح نافذة جديدة)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Source‎: Br J Haematol 2016;175(3):381-92.

مفهرسة‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (يفتح نافذة جديدة)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (يفتح نافذة جديدة)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Source‎: Blood Rev 2014;28(3):95-102.

مفهرسة‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (يفتح نافذة جديدة)

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. (يفتح نافذة جديدة)

Alperin JB

Source‎: JAMA 1987;258(14):1916-9.

مفهرسة‎: PubMed 3656602

DOI‎: 10.1001/jama.1987.03400140078028

https://www.ncbi.nlm.nih.gov/pubmed/3656602 (يفتح نافذة جديدة)

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (يفتح نافذة جديدة)

Crowther MA, McDonald E, Johnston M, Cook D

Source‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

مفهرسة‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (يفتح نافذة جديدة)

The use of fibrin sealant in burn operations. (يفتح نافذة جديدة)

Foster K

Source‎: Surgery 2007;142(4 Suppl):S50-4.

مفهرسة‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (يفتح نافذة جديدة)

Use of fibrin sealant in thermal injury. (يفتح نافذة جديدة)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Source‎: J Burn Care Rehabil 1997;18(5):429-34.

مفهرسة‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (يفتح نافذة جديدة)

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (يفتح نافذة جديدة)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Source‎: Br J Anaesth 2012;109(3):376-81.

مفهرسة‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (يفتح نافذة جديدة)

Transfusion in trauma: why and how should we change our current practice? (يفتح نافذة جديدة)

Theusinger OM, Spahn DR, Ganter MT.

Source‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

مفهرسة‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (يفتح نافذة جديدة)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (يفتح نافذة جديدة)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Source‎: Health Technol Assess 2015;19(58):1-228.

مفهرسة‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (يفتح نافذة جديدة)